Clearside Biomedical (CLSD) has released an update to notify the public and investors about an entry into a material definitive agreement.
Clearside Biomedical, Inc. has initiated a registered direct offering to sell over 11 million shares and corresponding warrants to institutional investors and an existing stockholder, aiming to raise approximately $15 million. Each share and warrant combo is priced at $1.35, with the warrants exercisable at $1.62 per share from August 2024 until August 2029. JMP Securities, LLC is serving as the placement agent for the transaction, which is set to close around February 9, 2024, provided all standard conditions are met.
For further insights into CLSD stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
